CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor.
about
The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis.Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapyHigh CTLA-4 expression correlates with poor prognosis in thymoma patients.On the Road to Immunotherapy-Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies
P2860
CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
CTLA-4 in mesothelioma patient ...... evance as a prognostic factor.
@en
CTLA-4 in mesothelioma patient ...... evance as a prognostic factor.
@nl
type
label
CTLA-4 in mesothelioma patient ...... evance as a prognostic factor.
@en
CTLA-4 in mesothelioma patient ...... evance as a prognostic factor.
@nl
prefLabel
CTLA-4 in mesothelioma patient ...... evance as a prognostic factor.
@en
CTLA-4 in mesothelioma patient ...... evance as a prognostic factor.
@nl
P2093
P2860
P50
P1476
CTLA-4 in mesothelioma patient ...... levance as a prognostic factor
@en
P2093
Alessandro Valentino
Anna Morabito
Antonella Vigani
Daniele Saverino
Franco Fedeli
Ilan Rosenberg
Maria Cristiana Franceschini
Massimo Romani
Paola Ferro
Pier Aldo Canessa
P2860
P2888
P304
P356
10.1007/S00262-016-1844-3
P577
2016-05-20T00:00:00Z